News Search Results

When a patient’s traditional treatment options are exhausted, sometimes there is an experimental drug—not yet approved by the FDA—that could be beneficial. Baystate's Human Research Protection Program may be able to help doctors get these treatments for their patients through the FDA's compassionate or emergency use process.

Baystate Franklin Medical Center celebrated the hospital’s receipt of a $1.8 million grant from the Massachusetts Health Policy Commission to strengthen the support system for patients with complex medical, behavioral and social needs in Franklin County, and reduce potentially avoidable hospital visits and admissions.

Baystate research interns support departmental researchers by performing a variety of behind-the-scenes tasks, such as  IRB paperwork and data collection.

“Research is an integral part of what we do at Baystate Health. We believe that a thriving clinical trials program for both adults and children is essential to being able to provide our patients with state-of-the art treatments,” said Dr. Peter David Friedmann, MPH, Baystate Health’s newly-appointed Chief Research Officer.

Baystate researcher Dr. Sarah Goff's Project ACCESS is bringing together patients, community leaders and researchers to identify and study health issues that are important to the Springfield community.

Baystate Health's Physician Liaison Program team is responsible for creating new relationships with local physicians, improving old ones, and better streamlining health care accessibility. 

New Chief Faculty Development Officer, Dr. Amy Gottlieb, plans to build an Office of Faculty Affairs at Baystate Health that will support the academic development of faculty at all levels.

Baystate researchers will be opening a number of clinical trials studying the effectiveness of targeted therapy for lung cancer.

Baystate is the only site in the western Massachusetts area participating in an international clinical trial testing whether statins can reduce the risk of heart disease in people with HIV infection, the REPRIEVE (Randomized Trial to Prevent Vascular Events in HIV) study.

Breast cancer risk and environmental exposure to common chemicals found in cosmetics and household products will be the focus of a five-year grant - expected to total $3.5 million - to a consortium of scientists at Baystate Medical Center, the Pioneer Valley Life Sciences Institute (PVLSI) and the Rays of Hope Center for Breast Cancer Research.